INVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating Arrowhead Pharmaceuticals, Inc. for Potential Breach of Fiduciary Duty Claims NEW YORK, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Fields Kupka & Shukurov LLP is investigating potential breach of fiduciary duty claims involving the board of directors of Arrowhead Pharmaceuticals,...

ARWR LOSS NOTICE: Rosen Law Firm Reminds Arrowhead Pharmaceuticals, Inc. Investors of Important Deadline in Class Action - ARWR NEW YORK, Jan. 06, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Arrowhead Pharmaceuticals, Inc. securities (NASDAQ:ARWR) from May 11, 2015...

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Arrowhead Pharmaceuticals, Inc. - ARWR NEW YORK, Dec. 23, 2016 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Arrowhead Pharmaceuticals,...

Robbins Arroyo LLP: Arrowhead Research Corporation (ARWR) Misled Shareholders According to a Recently Filed Class Action SAN DIEGO and PASADENA, Calif., Oct. 13, 2014 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins Arroyo LLP announces that an investor of Arrowhead Research Corporation (Nasdaq:ARWR) has filed a...